 | • レポートコード：MRC2-11QY02717 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は喘息・COPDのグローバル市場について調査・分析したレポートです。種類別（抗炎症薬、気管支拡張薬単剤療法、併用薬）市場規模、用途別（病院薬局、私立クリニック、ドラッグストア、小売薬局、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別喘息・COPDの競争状況、市場シェア ・世界の喘息・COPD市場：種類別市場規模 2015年-2020年（抗炎症薬、気管支拡張薬単剤療法、併用薬） ・世界の喘息・COPD市場：種類別市場規模予測 2021年-2026年（抗炎症薬、気管支拡張薬単剤療法、併用薬） ・世界の喘息・COPD市場：用途別市場規模 2015年-2020年（病院薬局、私立クリニック、ドラッグストア、小売薬局、Eコマース） ・世界の喘息・COPD市場：用途別市場規模予測 2021年-2026年（病院薬局、私立クリニック、ドラッグストア、小売薬局、Eコマース） ・北米の喘息・COPD市場分析：米国、カナダ ・ヨーロッパの喘息・COPD市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの喘息・COPD市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の喘息・COPD市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの喘息・COPD市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GSK、Novartis、Merck、Abbott、Boehringer Ingelheim、AstraZeneca、Roche、Teva、Vectura、Pfizer、Mylan、Allergan、Cipla、Akorn ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Chronic obstructive pulmonary disease (COPD) is a general term that describes progressive respiratory diseases like emphysema and chronic bronchitis. COPD is characterized by decreased airflow over time, as well as inflammation of the tissues that line the airway.
Asthma is usually considered a separate respiratory disease, but sometimes it’s mistaken for COPD. The two have similar symptoms. These symptoms include chronic coughing, wheezing, and shortness of breath.
Currently, North America leads the global market for asthma & COPD drugs and devices. North America was followed by Europe in terms of market capitalization. However, North America and Europe is expected to lose out some of the market share to other emerging regional markets owing to the expiry of several patens of pharmaceutical companies operating in these regions. Asia Pacific is expected to be the fastest regional market for asthma and COPD owing to the increased incidence of asthma & other respiratory diseases in industrial regions.
Market Analysis and Insights: Global Asthma & COPD Market
The global Asthma & COPD market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Asthma & COPD Scope and Market Size
Asthma & COPD market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Asthma & COPD market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Asthma & COPD market is segmented into
Anti-inflammatory Drugs
Bronchodilator Monotherapy
Combination Drugs
Segment by Application, the Asthma & COPD market is segmented into
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
Regional and Country-level Analysis
The Asthma & COPD market is analysed and market size information is provided by regions (countries).
The key regions covered in the Asthma & COPD market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Asthma & COPD Market Share Analysis
Asthma & COPD market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Asthma & COPD business, the date to enter into the Asthma & COPD market, Asthma & COPD product introduction, recent developments, etc.
The major vendors covered:
GSK
Novartis
Merck
Abbott
Boehringer Ingelheim
AstraZeneca
Roche
Teva
Vectura
Pfizer
Mylan
Allergan
Cipla
Akorn
1 Study Coverage
1.1 Asthma & COPD Product Introduction
1.2 Market Segments
1.3 Key Asthma & COPD Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Asthma & COPD Market Size Growth Rate by Type
1.4.2 Anti-inflammatory Drugs
1.4.3 Bronchodilator Monotherapy
1.4.4 Combination Drugs
1.5 Market by Application
1.5.1 Global Asthma & COPD Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Private Clinics
1.5.4 Drug Stores
1.5.5 Retail Pharmacies
1.5.6 E-Commerce
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Asthma & COPD Market Size, Estimates and Forecasts
2.1.1 Global Asthma & COPD Revenue 2015-2026
2.1.2 Global Asthma & COPD Sales 2015-2026
2.2 Global Asthma & COPD, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Asthma & COPD Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Asthma & COPD Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Asthma & COPD Competitor Landscape by Players
3.1 Asthma & COPD Sales by Manufacturers
3.1.1 Asthma & COPD Sales by Manufacturers (2015-2020)
3.1.2 Asthma & COPD Sales Market Share by Manufacturers (2015-2020)
3.2 Asthma & COPD Revenue by Manufacturers
3.2.1 Asthma & COPD Revenue by Manufacturers (2015-2020)
3.2.2 Asthma & COPD Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Asthma & COPD Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Asthma & COPD Revenue in 2019
3.2.5 Global Asthma & COPD Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Asthma & COPD Price by Manufacturers
3.4 Asthma & COPD Manufacturing Base Distribution, Product Types
3.4.1 Asthma & COPD Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Asthma & COPD Product Type
3.4.3 Date of International Manufacturers Enter into Asthma & COPD Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Asthma & COPD Market Size by Type (2015-2020)
4.1.1 Global Asthma & COPD Sales by Type (2015-2020)
4.1.2 Global Asthma & COPD Revenue by Type (2015-2020)
4.1.3 Asthma & COPD Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Asthma & COPD Market Size Forecast by Type (2021-2026)
4.2.1 Global Asthma & COPD Sales Forecast by Type (2021-2026)
4.2.2 Global Asthma & COPD Revenue Forecast by Type (2021-2026)
4.2.3 Asthma & COPD Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Asthma & COPD Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Asthma & COPD Market Size by Application (2015-2020)
5.1.1 Global Asthma & COPD Sales by Application (2015-2020)
5.1.2 Global Asthma & COPD Revenue by Application (2015-2020)
5.1.3 Asthma & COPD Price by Application (2015-2020)
5.2 Asthma & COPD Market Size Forecast by Application (2021-2026)
5.2.1 Global Asthma & COPD Sales Forecast by Application (2021-2026)
5.2.2 Global Asthma & COPD Revenue Forecast by Application (2021-2026)
5.2.3 Global Asthma & COPD Price Forecast by Application (2021-2026)
6 North America
6.1 North America Asthma & COPD by Country
6.1.1 North America Asthma & COPD Sales by Country
6.1.2 North America Asthma & COPD Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Asthma & COPD Market Facts & Figures by Type
6.3 North America Asthma & COPD Market Facts & Figures by Application
7 Europe
7.1 Europe Asthma & COPD by Country
7.1.1 Europe Asthma & COPD Sales by Country
7.1.2 Europe Asthma & COPD Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Asthma & COPD Market Facts & Figures by Type
7.3 Europe Asthma & COPD Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Asthma & COPD by Region
8.1.1 Asia Pacific Asthma & COPD Sales by Region
8.1.2 Asia Pacific Asthma & COPD Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Asthma & COPD Market Facts & Figures by Type
8.3 Asia Pacific Asthma & COPD Market Facts & Figures by Application
9 Latin America
9.1 Latin America Asthma & COPD by Country
9.1.1 Latin America Asthma & COPD Sales by Country
9.1.2 Latin America Asthma & COPD Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Asthma & COPD Market Facts & Figures by Type
9.3 Central & South America Asthma & COPD Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Asthma & COPD by Country
10.1.1 Middle East and Africa Asthma & COPD Sales by Country
10.1.2 Middle East and Africa Asthma & COPD Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Asthma & COPD Market Facts & Figures by Type
10.3 Middle East and Africa Asthma & COPD Market Facts & Figures by Application
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description and Business Overview
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Asthma & COPD Products Offered
11.1.5 GSK Related Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description and Business Overview
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Asthma & COPD Products Offered
11.2.5 Novartis Related Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description and Business Overview
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Asthma & COPD Products Offered
11.3.5 Merck Related Developments
11.4 Abbott
11.4.1 Abbott Corporation Information
11.4.2 Abbott Description and Business Overview
11.4.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Abbott Asthma & COPD Products Offered
11.4.5 Abbott Related Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Corporation Information
11.5.2 Boehringer Ingelheim Description and Business Overview
11.5.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Boehringer Ingelheim Asthma & COPD Products Offered
11.5.5 Boehringer Ingelheim Related Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Corporation Information
11.6.2 AstraZeneca Description and Business Overview
11.6.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.6.4 AstraZeneca Asthma & COPD Products Offered
11.6.5 AstraZeneca Related Developments
11.7 Roche
11.7.1 Roche Corporation Information
11.7.2 Roche Description and Business Overview
11.7.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Roche Asthma & COPD Products Offered
11.7.5 Roche Related Developments
11.8 Teva
11.8.1 Teva Corporation Information
11.8.2 Teva Description and Business Overview
11.8.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Teva Asthma & COPD Products Offered
11.8.5 Teva Related Developments
11.9 Vectura
11.9.1 Vectura Corporation Information
11.9.2 Vectura Description and Business Overview
11.9.3 Vectura Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Vectura Asthma & COPD Products Offered
11.9.5 Vectura Related Developments
11.10 Pfizer
11.10.1 Pfizer Corporation Information
11.10.2 Pfizer Description and Business Overview
11.10.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Pfizer Asthma & COPD Products Offered
11.10.5 Pfizer Related Developments
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description and Business Overview
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Asthma & COPD Products Offered
11.1.5 GSK Related Developments
11.12 Allergan
11.12.1 Allergan Corporation Information
11.12.2 Allergan Description and Business Overview
11.12.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Allergan Products Offered
11.12.5 Allergan Related Developments
11.13 Cipla
11.13.1 Cipla Corporation Information
11.13.2 Cipla Description and Business Overview
11.13.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Cipla Products Offered
11.13.5 Cipla Related Developments
11.14 Akorn
11.14.1 Akorn Corporation Information
11.14.2 Akorn Description and Business Overview
11.14.3 Akorn Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Akorn Products Offered
11.14.5 Akorn Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Asthma & COPD Market Estimates and Projections by Region
12.1.1 Global Asthma & COPD Sales Forecast by Regions 2021-2026
12.1.2 Global Asthma & COPD Revenue Forecast by Regions 2021-2026
12.2 North America Asthma & COPD Market Size Forecast (2021-2026)
12.2.1 North America: Asthma & COPD Sales Forecast (2021-2026)
12.2.2 North America: Asthma & COPD Revenue Forecast (2021-2026)
12.2.3 North America: Asthma & COPD Market Size Forecast by Country (2021-2026)
12.3 Europe Asthma & COPD Market Size Forecast (2021-2026)
12.3.1 Europe: Asthma & COPD Sales Forecast (2021-2026)
12.3.2 Europe: Asthma & COPD Revenue Forecast (2021-2026)
12.3.3 Europe: Asthma & COPD Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Asthma & COPD Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Asthma & COPD Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Asthma & COPD Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Asthma & COPD Market Size Forecast by Region (2021-2026)
12.5 Latin America Asthma & COPD Market Size Forecast (2021-2026)
12.5.1 Latin America: Asthma & COPD Sales Forecast (2021-2026)
12.5.2 Latin America: Asthma & COPD Revenue Forecast (2021-2026)
12.5.3 Latin America: Asthma & COPD Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Asthma & COPD Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Asthma & COPD Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Asthma & COPD Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Asthma & COPD Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Asthma & COPD Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Asthma & COPD Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Asthma & COPD Market Segments
Table 2. Ranking of Global Top Asthma & COPD Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Asthma & COPD Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Anti-inflammatory Drugs
Table 5. Major Manufacturers of Bronchodilator Monotherapy
Table 6. Major Manufacturers of Combination Drugs
Table 7. Global Asthma & COPD Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Asthma & COPD Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Asthma & COPD Sales by Regions 2015-2020 (K Units)
Table 10. Global Asthma & COPD Sales Market Share by Regions (2015-2020)
Table 11. Global Asthma & COPD Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Asthma & COPD Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Asthma & COPD Sales Share by Manufacturers (2015-2020)
Table 14. Global Asthma & COPD Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Asthma & COPD by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Asthma & COPD as of 2019)
Table 16. Asthma & COPD Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Asthma & COPD Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Asthma & COPD Price (2015-2020) (USD/Unit)
Table 19. Asthma & COPD Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Asthma & COPD Product Type
Table 21. Date of International Manufacturers Enter into Asthma & COPD Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Asthma & COPD Sales by Type (2015-2020) (K Units)
Table 24. Global Asthma & COPD Sales Share by Type (2015-2020)
Table 25. Global Asthma & COPD Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Asthma & COPD Revenue Share by Type (2015-2020)
Table 27. Asthma & COPD Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Asthma & COPD Sales by Application (2015-2020) (K Units)
Table 29. Global Asthma & COPD Sales Share by Application (2015-2020)
Table 30. North America Asthma & COPD Sales by Country (2015-2020) (K Units)
Table 31. North America Asthma & COPD Sales Market Share by Country (2015-2020)
Table 32. North America Asthma & COPD Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Asthma & COPD Revenue Market Share by Country (2015-2020)
Table 34. North America Asthma & COPD Sales by Type (2015-2020) (K Units)
Table 35. North America Asthma & COPD Sales Market Share by Type (2015-2020)
Table 36. North America Asthma & COPD Sales by Application (2015-2020) (K Units)
Table 37. North America Asthma & COPD Sales Market Share by Application (2015-2020)
Table 38. Europe Asthma & COPD Sales by Country (2015-2020) (K Units)
Table 39. Europe Asthma & COPD Sales Market Share by Country (2015-2020)
Table 40. Europe Asthma & COPD Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Asthma & COPD Revenue Market Share by Country (2015-2020)
Table 42. Europe Asthma & COPD Sales by Type (2015-2020) (K Units)
Table 43. Europe Asthma & COPD Sales Market Share by Type (2015-2020)
Table 44. Europe Asthma & COPD Sales by Application (2015-2020) (K Units)
Table 45. Europe Asthma & COPD Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Asthma & COPD Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Asthma & COPD Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Asthma & COPD Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Asthma & COPD Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Asthma & COPD Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Asthma & COPD Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Asthma & COPD Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Asthma & COPD Sales Market Share by Application (2015-2020)
Table 54. Latin America Asthma & COPD Sales by Country (2015-2020) (K Units)
Table 55. Latin America Asthma & COPD Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Asthma & COPD Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Asthma & COPD Revenue Market Share by Country (2015-2020)
Table 58. Latin America Asthma & COPD Sales by Type (2015-2020) (K Units)
Table 59. Latin America Asthma & COPD Sales Market Share by Type (2015-2020)
Table 60. Latin America Asthma & COPD Sales by Application (2015-2020) (K Units)
Table 61. Latin America Asthma & COPD Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Asthma & COPD Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Asthma & COPD Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Asthma & COPD Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Asthma & COPD Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Asthma & COPD Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Asthma & COPD Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Asthma & COPD Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Asthma & COPD Sales Market Share by Application (2015-2020)
Table 70. GSK Corporation Information
Table 71. GSK Description and Major Businesses
Table 72. GSK Asthma & COPD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. GSK Product
Table 74. GSK Recent Development
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Major Businesses
Table 77. Novartis Asthma & COPD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Novartis Product
Table 79. Novartis Recent Development
Table 80. Merck Corporation Information
Table 81. Merck Description and Major Businesses
Table 82. Merck Asthma & COPD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Merck Product
Table 84. Merck Recent Development
Table 85. Abbott Corporation Information
Table 86. Abbott Description and Major Businesses
Table 87. Abbott Asthma & COPD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Abbott Product
Table 89. Abbott Recent Development
Table 90. Boehringer Ingelheim Corporation Information
Table 91. Boehringer Ingelheim Description and Major Businesses
Table 92. Boehringer Ingelheim Asthma & COPD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Boehringer Ingelheim Product
Table 94. Boehringer Ingelheim Recent Development
Table 95. AstraZeneca Corporation Information
Table 96. AstraZeneca Description and Major Businesses
Table 97. AstraZeneca Asthma & COPD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. AstraZeneca Product
Table 99. AstraZeneca Recent Development
Table 100. Roche Corporation Information
Table 101. Roche Description and Major Businesses
Table 102. Roche Asthma & COPD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Roche Product
Table 104. Roche Recent Development
Table 105. Teva Corporation Information
Table 106. Teva Description and Major Businesses
Table 107. Teva Asthma & COPD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Teva Product
Table 109. Teva Recent Development
Table 110. Vectura Corporation Information
Table 111. Vectura Description and Major Businesses
Table 112. Vectura Asthma & COPD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Vectura Product
Table 114. Vectura Recent Development
Table 115. Pfizer Corporation Information
Table 116. Pfizer Description and Major Businesses
Table 117. Pfizer Asthma & COPD Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Pfizer Product
Table 119. Pfizer Recent Development
Table 120. Mylan Corporation Information
Table 121. Mylan Description and Major Businesses
Table 122. Mylan Asthma & COPD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Mylan Product
Table 124. Mylan Recent Development
Table 125. Allergan Corporation Information
Table 126. Allergan Description and Major Businesses
Table 127. Allergan Asthma & COPD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Allergan Product
Table 129. Allergan Recent Development
Table 130. Cipla Corporation Information
Table 131. Cipla Description and Major Businesses
Table 132. Cipla Asthma & COPD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Cipla Product
Table 134. Cipla Recent Development
Table 135. Akorn Corporation Information
Table 136. Akorn Description and Major Businesses
Table 137. Akorn Asthma & COPD Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Akorn Product
Table 139. Akorn Recent Development
Table 140. Global Asthma & COPD Sales Forecast by Regions (2021-2026) (K Units)
Table 141. Global Asthma & COPD Sales Market Share Forecast by Regions (2021-2026)
Table 142. Global Asthma & COPD Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 143. Global Asthma & COPD Revenue Market Share Forecast by Regions (2021-2026)
Table 144. North America: Asthma & COPD Sales Forecast by Country (2021-2026) (K Units)
Table 145. North America: Asthma & COPD Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Europe: Asthma & COPD Sales Forecast by Country (2021-2026) (K Units)
Table 147. Europe: Asthma & COPD Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Asia Pacific: Asthma & COPD Sales Forecast by Region (2021-2026) (K Units)
Table 149. Asia Pacific: Asthma & COPD Revenue Forecast by Region (2021-2026) (US$ Million)
Table 150. Latin America: Asthma & COPD Sales Forecast by Country (2021-2026) (K Units)
Table 151. Latin America: Asthma & COPD Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Middle East and Africa: Asthma & COPD Sales Forecast by Country (2021-2026) (K Units)
Table 153. Middle East and Africa: Asthma & COPD Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 155. Key Challenges
Table 156. Market Risks
Table 157. Main Points Interviewed from Key Asthma & COPD Players
Table 158. Asthma & COPD Customers List
Table 159. Asthma & COPD Distributors List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Asthma & COPD Product Picture
Figure 2. Global Asthma & COPD Sales Market Share by Type in 2020 & 2026
Figure 3. Anti-inflammatory Drugs Product Picture
Figure 4. Bronchodilator Monotherapy Product Picture
Figure 5. Combination Drugs Product Picture
Figure 6. Global Asthma & COPD Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Pharmacies
Figure 8. Private Clinics
Figure 9. Drug Stores
Figure 10. Retail Pharmacies
Figure 11. E-Commerce
Figure 12. Asthma & COPD Report Years Considered
Figure 13. Global Asthma & COPD Market Size 2015-2026 (US$ Million)
Figure 14. Global Asthma & COPD Sales 2015-2026 (K Units)
Figure 15. Global Asthma & COPD Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Asthma & COPD Sales Market Share by Region (2015-2020)
Figure 17. Global Asthma & COPD Sales Market Share by Region in 2019
Figure 18. Global Asthma & COPD Revenue Market Share by Region (2015-2020)
Figure 19. Global Asthma & COPD Revenue Market Share by Region in 2019
Figure 20. Global Asthma & COPD Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Asthma & COPD Revenue in 2019
Figure 22. Asthma & COPD Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Asthma & COPD Sales Market Share by Type (2015-2020)
Figure 24. Global Asthma & COPD Sales Market Share by Type in 2019
Figure 25. Global Asthma & COPD Revenue Market Share by Type (2015-2020)
Figure 26. Global Asthma & COPD Revenue Market Share by Type in 2019
Figure 27. Global Asthma & COPD Market Share by Price Range (2015-2020)
Figure 28. Global Asthma & COPD Sales Market Share by Application (2015-2020)
Figure 29. Global Asthma & COPD Sales Market Share by Application in 2019
Figure 30. Global Asthma & COPD Revenue Market Share by Application (2015-2020)
Figure 31. Global Asthma & COPD Revenue Market Share by Application in 2019
Figure 32. North America Asthma & COPD Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Asthma & COPD Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Asthma & COPD Sales Market Share by Country in 2019
Figure 35. North America Asthma & COPD Revenue Market Share by Country in 2019
Figure 36. U.S. Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Asthma & COPD Market Share by Type in 2019
Figure 41. North America Asthma & COPD Market Share by Application in 2019
Figure 42. Europe Asthma & COPD Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Asthma & COPD Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Asthma & COPD Sales Market Share by Country in 2019
Figure 45. Europe Asthma & COPD Revenue Market Share by Country in 2019
Figure 46. Germany Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Asthma & COPD Market Share by Type in 2019
Figure 57. Europe Asthma & COPD Market Share by Application in 2019
Figure 58. Asia Pacific Asthma & COPD Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Asthma & COPD Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Asthma & COPD Sales Market Share by Region in 2019
Figure 61. Asia Pacific Asthma & COPD Revenue Market Share by Region in 2019
Figure 62. China Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Asthma & COPD Market Share by Type in 2019
Figure 85. Asia Pacific Asthma & COPD Market Share by Application in 2019
Figure 86. Latin America Asthma & COPD Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Asthma & COPD Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Asthma & COPD Sales Market Share by Country in 2019
Figure 89. Latin America Asthma & COPD Revenue Market Share by Country in 2019
Figure 90. Mexico Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Asthma & COPD Market Share by Type in 2019
Figure 97. Latin America Asthma & COPD Market Share by Application in 2019
Figure 98. Middle East and Africa Asthma & COPD Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Asthma & COPD Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Asthma & COPD Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Asthma & COPD Revenue Market Share by Country in 2019
Figure 102. Turkey Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Asthma & COPD Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E Asthma & COPD Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Asthma & COPD Market Share by Type in 2019
Figure 109. Middle East and Africa Asthma & COPD Market Share by Application in 2019
Figure 110. North America Asthma & COPD Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. North America Asthma & COPD Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Asthma & COPD Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Europe Asthma & COPD Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Asthma & COPD Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Asia Pacific Asthma & COPD Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Asthma & COPD Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Latin America Asthma & COPD Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Asthma & COPD Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Middle East and Africa Asthma & COPD Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
COPD薬剤の世界市場（～2026年） COPD drugs is a medicine used to treatment chronic obstructive pulmonary disease, such as bronchodilators, pde-4 inhibitors， steroids, combination therapies, etc. One of the emerging trends propelling the growth prospects for this market is the augmented focus and use of combination therapies to tre…- 喘息治療薬の世界市場（～2026年） Market Analysis and Insights: Global Asthma Treatment Drugs Market The global Asthma Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Asthma Treatment Drugs Scope and Market Size Asthma Treatment Drugs m…
- 喘息薬の世界市場（～2026年） Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell …
- 予防喘息薬の世界市場（～2026年） Drugs for asthma attacks are bronchodilators. The products include pills, potions, inhalers and sprays. The effect is bronchiectasis, which can relieve asthma symptoms quickly and help prevent asthma attacks. This kind of medicine works well and is quite safe. But be careful not to overuse it. The m…
- 好酸球性喘息治療の世界市場（～2026年） Eosinophilic asthma is a form of asthma categorized by greater levels of eosinophils in the air passages. Eosinophilic Asthma Treatment market is driven by increasing pollution and lowering immunity in the population. Susceptibility of allergies within individuals has increased resulting in the incr…